124 related articles for article (PubMed ID: 8903838)
1. Immunoreactive tachykinins in 24-h collections of urine from patients with carcinoid tumours: characterization and correlation with plasma concentrations.
Bergstrom M; Theodorsson E; Norheim I; Oberg K
Scand J Clin Lab Invest; 1995 Dec; 55(8):679-89. PubMed ID: 8903838
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.
Theodorsson-Norheim E; Norheim I; Oberg K; Brodin E; Lundberg JM; Tatemoto K; Lindgren PG
Biochem Biophys Res Commun; 1985 Aug; 131(1):77-83. PubMed ID: 2412557
[TBL] [Abstract][Full Text] [Related]
3. Tachykinin production by carcinoid tumours in culture.
Norheim I; Wilander E; Oberg K; Theodorsson-Norheim E; Lundqvist ML; Lindgren P; Bergh J
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):689-95. PubMed ID: 3477459
[TBL] [Abstract][Full Text] [Related]
4. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
[TBL] [Abstract][Full Text] [Related]
5. Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush.
Conlon JM; Deacon CF; Richter G; Stöckmann F; Creutzfeldt W
Scand J Gastroenterol; 1987 Jan; 22(1):97-105. PubMed ID: 2882598
[TBL] [Abstract][Full Text] [Related]
6. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
[TBL] [Abstract][Full Text] [Related]
7. Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours.
Conlon JM; Deacon CF; Richter G; Schmidt WE; Stöckmann F; Creutzfeldt W
Regul Pept; 1986 Jan; 13(2):183-96. PubMed ID: 3006157
[TBL] [Abstract][Full Text] [Related]
8. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
[TBL] [Abstract][Full Text] [Related]
9. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system.
Arai H; Emson PC
Brain Res; 1986 Dec; 399(2):240-9. PubMed ID: 2435360
[TBL] [Abstract][Full Text] [Related]
10. Antisera raised against eledoisin and kassinin detect elevated levels of immunoreactive material in plasma and tumor tissues from patients with carcinoid tumors.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K; Lundqvist G; Rosell S
Regul Pept; 1984 Nov; 9(4):245-57. PubMed ID: 6084259
[TBL] [Abstract][Full Text] [Related]
11. Motilin in plasma and tumor tissues from patients with the carcinoid syndrome. Possible involvement in the increased frequency of bowel movements.
Oberg K; Theodorsson-Norheim E; Norheim I
Scand J Gastroenterol; 1987 Nov; 22(9):1041-8. PubMed ID: 2447632
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin A, neurokinin B and neuropeptide K in the rabbit iris: a study comparing different extraction methods.
Beding-Barnekow B; Brodin E
Regul Pept; 1989 May; 25(2):199-206. PubMed ID: 2547226
[TBL] [Abstract][Full Text] [Related]
13. Capsaicin-sensitive tachykinin-like immunoreactivity in the thymus of rats and guinea-pigs.
Geppetti P; Theodorsson-Norheim E; Ballerini G; Alessandri M; Maggi CA; Santicioli P; Amenta F; Fanciullacci M
J Neuroimmunol; 1988 Aug; 19(1-2):3-9. PubMed ID: 2456305
[TBL] [Abstract][Full Text] [Related]
14. The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.
Oberg K; Norheim I; Theodorsson E; Ahlman H; Lundqvist G; Wide L
J Clin Endocrinol Metab; 1989 Apr; 68(4):796-800. PubMed ID: 2466045
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical distribution, biochemical characterization, and biological action of tachykinins in the frog adrenal gland.
Leboulenger F; Vaglini L; Conlon JM; Homo-Delarche F; Wang Y; Kerdelhue B; Pelletier G; Vaudry H
Endocrinology; 1993 Nov; 133(5):1999-2008. PubMed ID: 7691584
[TBL] [Abstract][Full Text] [Related]
16. Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease.
Makridis C; Theodorsson E; Akerström G; Oberg K; Knutson L
J Gastroenterol Hepatol; 1999 May; 14(5):500-7. PubMed ID: 10355517
[TBL] [Abstract][Full Text] [Related]
17. Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methods.
Brodin E; Rosén A; Theodorsson E; Jonczyk A; Sandberg BE; Brodin K
Regul Pept; 1994 Jul; 52(2):97-110. PubMed ID: 7526421
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour.
Theodorsson-Norheim E; Jörnvall H; Andersson M; Norheim I; Oberg K; Jacobsson G
Eur J Biochem; 1987 Aug; 166(3):693-7. PubMed ID: 3038549
[TBL] [Abstract][Full Text] [Related]
19. Occurrence and effects of multiple tachykinins; substance P, neurokinin A and neuropeptide K in human lower airways.
Martling CR; Theodorsson-Norheim E; Lundberg JM
Life Sci; 1987 Apr; 40(16):1633-43. PubMed ID: 2436021
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical characterisation of tachykinin immunoreactivity in the nervous system of the garden snail, Helix aspersa.
Leung PS; Shaw C; Johnston CF; Irvine GB
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Sep; 103(1):169-73. PubMed ID: 1280545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]